CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Recent advances in drug discovery technology have led to significant progress in accelerating drug target identification, lead generation, lead optimization, and the development of clinical drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback